HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Tinea capitis — Clinical Guidelines

Overview

Tinea capitis is a dermatophyte infection primarily affecting children, characterized by inflammation of the scalp and hair shafts, often requiring systemic antifungal therapy. 1 2 3

Diagnosis

Key Diagnostic Criteria: Clinical presentation with scalp lesions, hair breakage, and sometimes kerion formation.

Recommended Tests:

- Dermatophyte PCR: Highly sensitive (100% at baseline) for initial diagnosis, though specificity during treatment can vary (84%). 1 - Microscopic Examination: Less sensitive (60% at baseline) but useful for rapid screening. 1 - Fungal Culture: Moderate sensitivity (87% at baseline) for species identification, highly specific (100%) during treatment. 1

False Positives/Negatives: PCR may yield false positives initially, resolving after 4 weeks; false negatives can occur during treatment monitoring. 1

Management

First-Line Treatments:

- Oral Antifungals: Griseofulvin (dose specifics not provided in abstracts) is commonly used, though newer agents like terbinafine or itraconazole may be considered based on resistance patterns. 4

Adjunctive Treatments:

- Topical Antifungals: Often used in conjunction with oral therapy to enhance efficacy and manage local symptoms. 1

Duration: Treatment typically lasts several weeks, often 4-6 weeks or longer depending on response and species involved. 1

Special Populations

Pediatrics: Tinea capitis predominantly affects children, with specific epidemiological trends noted in different regions (e.g., higher incidence in prepubertal children in Korea, Afro-Caribbean hair type in southeast London). 3 4

Comorbidities: No specific management adjustments mentioned for comorbidities in the provided abstracts. 1 3 4

Key Recommendations

Utilize dermatophyte PCR for initial diagnosis due to its high sensitivity (100%) compared to traditional methods like microscopy and culture. (Evidence: Strong 1)

Monitor treatment response with PCR cautiously, noting potential for false negatives during therapy; confirm with repeat testing if clinical improvement is not observed. (Evidence: Moderate 1)

Implement public health initiatives and appropriate oral antifungal therapy to control and reduce the incidence of tinea capitis, particularly in endemic areas like sub-Saharan Africa. (Evidence: Moderate 2 3)

References

1 Theiler M, Luchsinger I, Rast AC, Schwieger-Briel A, Weibel L, Bosshard PP. Precision diagnostics in paediatric dermatology: Advancing management of tinea capitis through dermatophyte PCR. Journal of the European Academy of Dermatology and Venereology : JEADV 2025. link 2 Bongomin F, Olum R, Nsenga L, Namusobya M, Russell L, de Sousa E et al.. Estimation of the burden of tinea capitis among children in Africa. Mycoses 2021. link 3 Lee WJ, Lee EH, Bang YJ, Jun JB. Retrospective two-centre study on prepubertal children with Tinea capitis in Korea. Mycoses 2020. link 4 Fuller LC, Child FC, Midgley G, Higgins EM. Scalp ringworm in south-east London and an analysis of a cohort of patients from a paediatric dermatology department. The British journal of dermatology 2003. link

Tinea capitis